These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15221866)

  • 41. Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation.
    Chain JL; Martin AK; Mack DG; Maier LA; Palmer BE; Fontenot AP
    J Immunol; 2013 Aug; 191(4):1648-56. PubMed ID: 23851684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
    Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M
    Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rottlerin inhibits human T cell responses.
    Springael C; Thomas S; Rahmouni S; Vandamme A; Goldman M; Willems F; Vosters O
    Biochem Pharmacol; 2007 Feb; 73(4):515-25. PubMed ID: 17141738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenytoin desensitization monitored by antigen specific T cell response using carboxyfluorescein succinimidyl ester dilution assay.
    Okumura A; Tsuge I; Kubota T; Kurahashi H; Natsume J; Negoro T; Watanabe K
    Eur J Paediatr Neurol; 2007 Nov; 11(6):385-8. PubMed ID: 17428709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40).
    Zaunders JJ; Munier ML; Seddiki N; Pett S; Ip S; Bailey M; Xu Y; Brown K; Dyer WB; Kim M; de Rose R; Kent SJ; Jiang L; Breit SN; Emery S; Cunningham AL; Cooper DA; Kelleher AD
    J Immunol; 2009 Aug; 183(4):2827-36. PubMed ID: 19635903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nitric oxide attenuates beryllium-induced IFNgamma responses in chronic beryllium disease: evidence for mechanisms independent of IL-18.
    Barna BP; Dweik RA; Farver CF; Culver D; Yen-Lieberman B; Thomassen MJ
    Clin Immunol; 2002 May; 103(2):169-75. PubMed ID: 12027422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro nonspecific mitogenic response of T-cell subsets in acute and chronic brucellosis.
    Kinikli S; Turkcapar N; Kucukay MB; Keskin G; Kinikli G
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):229-33. PubMed ID: 15893904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test.
    Amicosante M; Deubner D; Saltini C
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):175-9. PubMed ID: 16315779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A role for cell adhesion in beryllium-mediated lung disease.
    Hong-Geller E
    J Occup Environ Hyg; 2009 Dec; 6(12):727-31; quiz D102-3. PubMed ID: 19894172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluoxetine directly counteracts the adverse effects of chronic stress on T cell immunity by compensatory and specific mechanisms.
    Frick LR; Rapanelli M; Cremaschi GA; Genaro AM
    Brain Behav Immun; 2009 Jan; 23(1):36-40. PubMed ID: 18625298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
    Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
    J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MICA antigens stimulate T cell proliferation and cell-mediated cytotoxicity.
    Zhang Y; Stastny P
    Hum Immunol; 2006 Mar; 67(3):215-22. PubMed ID: 16698445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
    Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
    Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume.
    Cullen MR; Kominsky JR; Rossman MD; Cherniack MG; Rankin JA; Balmes JR; Kern JA; Daniele RP; Palmer L; Naegel GP
    Am Rev Respir Dis; 1987 Jan; 135(1):201-8. PubMed ID: 3492158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.
    Fontenot AP; Palmer BE; Sullivan AK; Joslin FG; Wilson CC; Maier LA; Newman LS; Kotzin BL
    J Clin Invest; 2005 Oct; 115(10):2886-93. PubMed ID: 16151531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of lymphocyte proliferation: CFSE kills dividing cells and modulates expression of activation markers.
    Last'ovicka J; Budinský V; Spísek R; Bartůnková J
    Cell Immunol; 2009; 256(1-2):79-85. PubMed ID: 19233349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation.
    Falta MT; Crawford JC; Tinega AN; Landry LG; Crawford F; Mack DG; Martin AK; Atif SM; Li L; Santos RG; Nakayama M; Kappler JW; Maier LA; Thomas PG; Pinilla C; Fontenot AP
    J Clin Invest; 2021 May; 131(9):. PubMed ID: 33630763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease.
    Dobis DR; Sawyer RT; Gillespie MM; Huang J; Newman LS; Maier LA; Day BJ
    Am J Respir Crit Care Med; 2008 May; 177(9):1002-11. PubMed ID: 18218990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Beryllium--underestimated occupational health hazard in Poland].
    Dudek W; Walusiak J; Wittczak T
    Med Pr; 2001; 52(6):471-8. PubMed ID: 11928678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway.
    Ou D; Wang X; Metzger DL; Ao Z; Pozzilli P; James RF; Chen L; Warnock GL
    Cell Transplant; 2006; 15(5):399-410. PubMed ID: 16970282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.